Natera, Inc. Common Stock vs. Veracyte, Inc.
Veracyte, Inc. (VCYT) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| NTRA | VCYT | |
|---|---|---|
| Market Cap | $59.58 billion | $3.70 billion |
| Revenue (TTM) | $2.71 billion | $561.90 million |
| Net Income (TTM) | $-192,346,000 | $114.48 million |
NTRA leads on 2 of 3 size & scale factors.
Valuation
| NTRA | VCYT | |
|---|---|---|
| P/E Ratio | — | 31.56 |
| Price / Book | 32.71 | 2.67 |
| Price / Sales | 22.01 | 6.59 |
VCYT leads on 2 of 2 valuation factors.
Profitability
| NTRA | VCYT | |
|---|---|---|
| Net Margin | -7.11% | 20.37% |
| Return on Equity | -10.56% | 8.25% |
VCYT leads on 2 of 2 profitability factors.
Risk & Sentiment
| NTRA | VCYT | |
|---|---|---|
| Short Interest | 0.96% | 0.83% |
VCYT leads on 1 of 1 risk & sentiment factors.
Dig deeper: NTRA overview, NTRA financials, VCYT overview, VCYT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.